Skip to main content
SpringerLink
Log in

Prostatakarzinom: Nachsorge

  • Living reference work entry
  • First Online:
Uroonkologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 20 Accesses

Zusammenfassung

In der aktuellen S3 Leitlinie wurden für die Nachsorge des Prostatakarzinoms verschiedene Empfehlungen ausgesprochen (S3 Leitlinie Prostatakarzinom Version 5.1; Mai 2019).

Asymptomatische Patienten nach lokaler kurativ intendierter Therapie sollen dieser Empfehlung zufolge innerhalb von zwölf Wochen nach Ende der Therapie eine erste Nachsorgeuntersuchung erhalten.

In den ersten beiden Jahren nach Therapie soll bei asymptomatischen Patienten alle 3 Monate nachgesorgt werden ab dem dritten Jahr halbjährlich.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Afshar-Oromieh A, Avtzi E, Giesel FL, Holland-Letz T et al (2015) The diagnostic value of PET/CT imaging with the (68)Ga-labelledPSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging 42(2):197–209. https://doi.org/10.1007/s00259-014-2949-6. Epub 4 Nov 20. PMID: 25411132; PMCID: PMC4315487

    Article  CAS  Google Scholar 

  • Akyol F, Ozyigit G, Selek U et al (2005) PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone. Eur Urol 48(1):40–45

    Article  CAS  Google Scholar 

  • Boccon-Gibod L, Djavan WB, Hammerer P et al (2004) Management of prostate-specific antigen relapse in prostate cancer: a European Consensus. Int J Clin Pract 58(4):382–390

    Article  CAS  Google Scholar 

  • Fraum TJ, Ludwig DR, Kim EH, Schroeder P, Hope TA, Ippolito JE (2018) Prostate cancer PET tracers: essentials for the urologist. Can J Urol 25(4):9371–9383

    Google Scholar 

  • Ciezki JP, Reddy CA, Garcia J et al (2005) PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time. Int J Radiat Oncol Biol Phys 64(2):512–517. https://doi.org/10.1016/j.ijrobp.2005.07.960. Epub 2005 Oct 6

  • Connolly JA, Shinohara K, Presti JC Jr et al (1996) Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology 47(2):225–231

    Article  CAS  Google Scholar 

  • Diblasio CJ, Kattan MW (2003) Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer. Urology 62(Suppl 1):9–18

    Article  Google Scholar 

  • Foster LS, Jajodia P, Fournier G, Jr et al (1993) The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy. J Urol 149(5):1024–1028

    Article  CAS  Google Scholar 

  • Gomez P, Manoharan M, Kim SS et al (2004) Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? BJU Int 94(3):299–302

    Article  Google Scholar 

  • Hricak H, Schoder H, Pucar D et al (2003) Advances in imaging in the postoperative patient with a rising prostate-specific antigen level. Semin Oncol 30(5):616–634

    Article  Google Scholar 

  • Kane CJ, Amling CL, Johnstone PA et al (2003) Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy. Urology 61(3):607–611

    Article  Google Scholar 

  • Kattan MW, Eastham J (2003) Algorithms for prostate-specific antigen recurrence after treatment of localized prostate cancer. Clin Prostate Cancer 1(4):221–226

    Article  Google Scholar 

  • Kerr J, Engel J, Schlesinger-Raab A et al (2003) Communication, quality of life and age: results of a 5-year prospective study in breast cancer patients. Ann Oncol 14(3):421–427

    Article  CAS  Google Scholar 

  • Leventis AK, Shariat SF, Kattan MW et al (2001) Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol 19(4):1030–1039

    Article  CAS  Google Scholar 

  • Pound CR, Partin AW, Eisenberger MA et al (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281(17):1591–1597

    Article  CAS  Google Scholar 

  • Ramsden AR, Chodak G (2004) An analysis of risk factors for biochemical progression in patients with seminal vesicle invasion: validation of Kattan's nomogram in a pathological subgroup. BJU Int 93(7):961–964

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Helios Klinikum Berlin Buch, Klinik für Urologie, Berlin, Deutschland

    Mark Schrader

  2. Kurt Miller Charité Unversitätsmedizin, Klinik Steglitz der FU Berlin, Berlin, Deutschland

    Kurt Miller

Authors
  1. Mark Schrader
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kurt Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark Schrader .

Editor information

Editors and Affiliations

  1. Helios Marien Klinikum Duisburg, Duisburg, Nordrhein-Westfalen, Deutschland

    Herbert Rübben

  2. Caritaskrankenhaus St. Josef, Regensburg, Deutschland

    Maximilian Burger

  3. Klinik und Poliklinik für Urologie, Universitätsklinikum Jena, Jena, Thüringen, Deutschland

    Marc-Oliver Grimm

  4. Urologische Klinik/Poliklinik, Universitätsklinikum Rostock, Rostock, Mecklenburg-Vorpommern, Deutschland

    Oliver Hakenberg

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Schrader, M., Miller, K. (2022). Prostatakarzinom: Nachsorge. In: Rübben, H., Burger, M., Grimm, MO., Hakenberg, O. (eds) Uroonkologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54652-9_59-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-54652-9_59-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-54652-9

  • Online ISBN: 978-3-662-54652-9

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation